Liat Vidal

Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials

Liat Vidal, Anat Gafter‐Gvili, Gilles Salles et al. · JNCI Journal of the National Cancer Institute · 2011 · 130 citations

Systematic Review, Lymphoid Neoplasia, Oncology +13

Systematic comparison of four sources of drug information regarding adjustment of dose for renal function

Liat Vidal, Maya Shavit, Abigail Fraser et al. · BMJ · 2005 · 117 citations · Full text

A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: Final results of a PMH, Chicago and California consortia trial

Hal W. Hirte, Liat Vidal, Gini F. Fleming et al. · Journal of Clinical Oncology · 2008 · 83 citations

Final Results, Tumoral Pathology, Gastrointestinal Oncology +14

Reported skin cancer screening of US adult workers

William G. LeBlanc, Liat Vidal, Robert S. Kirsner et al. · Journal of the American Academy of Dermatology · 2008 · 72 citations

Workplace Health Surveillance, Cancer Screening, Medicine +5

Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

Drorit Merkel, Kalman Filanovsky, Anat Gafter‐Gvili et al. · American Journal of Hematology · 2012 · 67 citations · Full text